Search

El estudio más grande y más completo de su tipo, realizado por el Memorial Sloan Kettering Cancer Center, concluye que la biología del cáncer colorrectal en personas menores de 50 años es muy similar a la de los pacientes de mayor edad, y que podría no estar justificado aplicar tratamientos más agresivos en los pacientes más jóvenes.

… Wednesday, August 18, 2021 ¿Podría el cáncer colorrectal en las personas menores de 50 años ser biológicamente diferente y más agresivo que el cáncer colorrectal en las personas mayores? Eso es lo que algunos investigadores han propuesto, ya que las personas de 20, 30 y 40 años se enfrentan a un aumento

Memorial Sloan Kettering researchers will explore "C dots" for tumor detection and treatment.

… Friday, May 1, 2009 Summary Memorial Sloan Kettering researchers will explore “C dots” for tumor detection and treatment. Researchers Will Explore “C Dots” for Tumor Detection and Treatment What if a tumor could be lit up by a fluorescent imaging agent, or probe, that is safe, biologically stable, and

MSK’s Pamela Drullinsky, MD, a breast medical oncologist and Regional Care Network Medical Site Director of MSK Nassau, joined one of her patients on a recent segment on Noticiero Telemundo 47 for breast cancer awareness month.

… Friday, November 5, 2021 MSK’s  Pamela Drullinsky , MD, a breast medical oncologist and Regional Care Network Medical Site Director of MSK Nassau, joined one of her patients on a recent segment on Noticiero Telemundo 47  for breast cancer awareness month. The story highlighted Rosa Martinez’s personal

La Dra. Pamela Drullinsky, oncóloga médica de MSK especialista en mamas y directora médica del sitio de la Red Regional de Atención MSK Nassau, acompañó recientemente a una de sus pacientes en un segmento del Noticiero Telemundo 47 por el mes de concientización sobre el cáncer de mama.

… Friday, November 5, 2021 La Dra. Pamela Drullinsky , oncóloga médica de MSK especialista en mamas y directora médica del sitio de la Red Regional de Atención MSK Nassau, acompañó recientemente a una de sus pacientes en un segmento del Noticiero Telemundo 47  por el mes de concientización sobre el cáncer

Nikki Chotas, who uses the pronouns they/them, has dedicated much of their life to speaking up for and working to empower those who may feel helpless and without a voice. They attribute their pursuits in part to feeling voiceless in their younger years.

… Wednesday, June 29, 2022 Nikki Chotas, who uses the pronouns they/them, has dedicated much of their life to speaking up for and working to empower those who may feel helpless and without a voice. They attribute their pursuits in part to feeling voiceless in their younger years.   “I had dark days. I

Cancer is tough, no matter the age. But adolescents and young adults with cancer face a whole host of unique challenges, including delayed diagnoses. MSK created an Adolescent and Young Adult (AYA at MSK) program which unites experts across 16 specialties.

… Thursday, September 17, 2020 Cancer is tough, no matter the age. But adolescents and young adults with cancer face a whole host of unique challenges, including delayed diagnoses. For years, MSK has worked to close the gap between pediatric and adult patients and to improve the experience for people in

Childhood leukemia expert Melvyn Greaves received The Society of Memorial Sloan Kettering Prize at the 2018 Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) commencement.

… Thursday, June 7, 2018 Summary Childhood leukemia expert Melvyn Greaves received The Society of Memorial Sloan Kettering Prize at the 2018 Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) commencement. At this year’s Gerstner Sloan Kettering Graduate School of Biomedical Sciences

Learn how MSK cares for transgender cancer patients, treating them with respect and medical expertise. Staff are specially trained to understand their needs.

… Friday, May 31, 2024 As Susan Everson lay in bed recovering from colorectal cancer surgery at Memorial Sloan Kettering Cancer Center (MSK), a nurse walked into her room with bag of cosmetics and a big dose of compassion. Using her skills as a professionally trained makeup artist, she’d come to help Susan

A study led by postdoctoral researcher Yanan Ma from the lab of cell biologist Philipp Niethammer shows why diversity also matters in model animal research.

… Tuesday, January 10, 2023 In science, how you ask a question is often as important as what you ask. Philipp Niethammer Philipp Niethammer, PhD The lab of cell biologist Philipp Niethammer, PhD , of the Sloan Kettering Institute at Memorial Sloan Kettering Cancer Center (MSK), studies fast-acting mechanisms

Investigators are looking at how and why the breast cancer drug trastuzumab sometimes causes long-lasting and potentially serious cardiac side effects.

… Thursday, October 19, 2017 Summary The breast cancer drug trastuzumab, which targets a protein called HER2, can cause long-lasting and potentially serious cardiac side effects. Researchers are using stem cells to study why this happens and to look for ways to prevent it. For people with breast cancer